These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38815585)

  • 1. MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature.
    Karayol R; Borroto MC; Haghshenas S; Namasivayam A; Reilly J; Levy MA; Relator R; Kerkhof J; McConkey H; Shvedunova M; Petersen AK; Magnussen K; Zweier C; Vasileiou G; Reis A; Savatt JM; Mulligan MR; Bicknell LS; Poke G; Abu-El-Haija A; Duis J; Hannig V; Srivastava S; Barkoudah E; Hauser NS; van den Born M; Hamiel U; Henig N; Baris Feldman H; McKee S; Krapels IPC; Lei Y; Todorova A; Yordanova R; Atemin S; Rogac M; McConnell V; Chassevent A; Barañano KW; Shashi V; Sullivan JA; Peron A; Iascone M; Canevini MP; Friedman J; Reyes IA; Kierstein J; Shen JJ; Ahmed FN; Mao X; Almoguera B; Blanco-Kelly F; Platzer K; Treu AB; Quilichini J; Bourgois A; Chatron N; Januel L; Rougeot C; Carere DA; Monaghan KG; Rousseau J; Myers KA; Sadikovic B; Akhtar A; Campeau PM
    Am J Hum Genet; 2024 Jul; 111(7):1330-1351. PubMed ID: 38815585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPEN haploinsufficiency causes a neurodevelopmental disorder overlapping proximal 1p36 deletion syndrome with an episignature of X chromosomes in females.
    Radio FC; Pang K; Ciolfi A; Levy MA; Hernández-García A; Pedace L; Pantaleoni F; Liu Z; de Boer E; Jackson A; Bruselles A; McConkey H; Stellacci E; Lo Cicero S; Motta M; Carrozzo R; Dentici ML; McWalter K; Desai M; Monaghan KG; Telegrafi A; Philippe C; Vitobello A; Au M; Grand K; Sanchez-Lara PA; Baez J; Lindstrom K; Kulch P; Sebastian J; Madan-Khetarpal S; Roadhouse C; MacKenzie JJ; Monteleone B; Saunders CJ; Jean Cuevas JK; Cross L; Zhou D; Hartley T; Sawyer SL; Monteiro FP; Secches TV; Kok F; Schultz-Rogers LE; Macke EL; Morava E; Klee EW; Kemppainen J; Iascone M; Selicorni A; Tenconi R; Amor DJ; Pais L; Gallacher L; Turnpenny PD; Stals K; Ellard S; Cabet S; Lesca G; Pascal J; Steindl K; Ravid S; Weiss K; Castle AMR; Carter MT; Kalsner L; de Vries BBA; van Bon BW; Wevers MR; Pfundt R; Stegmann APA; Kerr B; Kingston HM; Chandler KE; Sheehan W; Elias AF; Shinde DN; Towne MC; Robin NH; Goodloe D; Vanderver A; Sherbini O; Bluske K; Hagelstrom RT; Zanus C; Faletra F; Musante L; Kurtz-Nelson EC; Earl RK; Anderlid BM; Morin G; van Slegtenhorst M; Diderich KEM; Brooks AS; Gribnau J; Boers RG; Finestra TR; Carter LB; Rauch A; Gasparini P; Boycott KM; Barakat TS; Graham JM; Faivre L; Banka S; Wang T; Eichler EE; Priolo M; Dallapiccola B; Vissers LELM; Sadikovic B; Scott DA; Holder JL; Tartaglia M
    Am J Hum Genet; 2021 Mar; 108(3):502-516. PubMed ID: 33596411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel protein-truncating variants of a chromatin-modifying gene MSL2 in syndromic neurodevelopmental disorders.
    Lu X; Ng K; Pinto E Vairo F; Collins J; Cohn R; Riley K; Agre K; Gavrilova R; Klee EW; Rosenfeld JA; Jiang YH
    Eur J Hum Genet; 2024 Jul; 32(7):879-883. PubMed ID: 38702431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo mutations in MSL3 cause an X-linked syndrome marked by impaired histone H4 lysine 16 acetylation.
    Basilicata MF; Bruel AL; Semplicio G; Valsecchi CIK; Aktaş T; Duffourd Y; Rumpf T; Morton J; Bache I; Szymanski WG; Gilissen C; Vanakker O; Õunap K; Mittler G; van der Burgt I; El Chehadeh S; Cho MT; Pfundt R; Tan TY; Kirchhoff M; Menten B; Vergult S; Lindstrom K; Reis A; Johnson DS; Fryer A; McKay V; ; Fisher RB; Thauvin-Robinet C; Francis D; Roscioli T; Pajusalu S; Radtke K; Ganesh J; Brunner HG; Wilson M; Faivre L; Kalscheuer VM; Thevenon J; Akhtar A
    Nat Genet; 2018 Oct; 50(10):1442-1451. PubMed ID: 30224647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.
    Muir AM; Gardner JF; van Jaarsveld RH; de Lange IM; van der Smagt JJ; Wilson GN; Dubbs H; Goldberg EM; Zitano L; Bupp C; Martinez J; Srour M; Accogli A; Alhakeem A; Meltzer M; Gropman A; Brewer C; Caswell RC; Montgomery T; McKenna C; McKee S; Powell C; Vasudevan PC; Brady AF; Joss S; Tysoe C; Noh G; Tarnopolsky M; Brady L; Zafar M; Schrier Vergano SA; Murray B; Sawyer L; Hainline BE; Sapp K; DeMarzo D; Huismann DJ; Wentzensen IM; Schnur RE; Monaghan KG; Juusola J; Rhodes L; Dobyns WB; Lecoquierre F; Goldenberg A; Polster T; Axer-Schaefer S; Platzer K; Klöckner C; Hoffman TL; MacArthur DG; O'Leary MC; VanNoy GE; England E; Varghese VC; Mefford HC
    Genet Med; 2021 May; 23(5):881-887. PubMed ID: 33473207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Novo KAT5 Variants Cause a Syndrome with Recognizable Facial Dysmorphisms, Cerebellar Atrophy, Sleep Disturbance, and Epilepsy.
    Humbert J; Salian S; Makrythanasis P; Lemire G; Rousseau J; Ehresmann S; Garcia T; Alasiri R; Bottani A; Hanquinet S; Beaver E; Heeley J; Smith ACM; Berger SI; Antonarakis SE; Yang XJ; Côté J; Campeau PM
    Am J Hum Genet; 2020 Sep; 107(3):564-574. PubMed ID: 32822602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo missense variants in HDAC3 leading to epigenetic machinery dysfunction are associated with a variable neurodevelopmental disorder.
    Yoon JG; Lim SK; Seo H; Lee S; Cho J; Kim SY; Koh HY; Poduri AH; Ramakumaran V; Vasudevan P; de Groot MJ; Ko JM; Han D; Chae JH; Lee CH
    Am J Hum Genet; 2024 Aug; 111(8):1588-1604. PubMed ID: 39047730
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Roston A; Evans D; Gill H; McKinnon M; Isidor B; Cogné B; Mwenifumbo J; van Karnebeek C; An J; Jones SJM; Farrer M; Demos M; Connolly M; Gibson WT; ;
    J Med Genet; 2021 Mar; 58(3):196-204. PubMed ID: 32546566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy.
    Usmani MA; Ahmed ZM; Magini P; Pienkowski VM; Rasmussen KJ; Hernan R; Rasheed F; Hussain M; Shahzad M; Lanpher BC; Niu Z; Lim FY; Pippucci T; Ploski R; Kraus V; Matuszewska K; Palombo F; Kianmahd J; ; Martinez-Agosto JA; Lee H; Colao E; Motazacker MM; Brigatti KW; Puffenberger EG; Riazuddin SA; Gonzaga-Jauregui C; Chung WK; Wagner M; Schultz MJ; Seri M; Kievit AJA; Perrotti N; Wassink-Ruiter JSK; van Bokhoven H; Riazuddin S; Riazuddin S
    Am J Hum Genet; 2021 Jul; 108(7):1330-1341. PubMed ID: 34102099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRSF1 haploinsufficiency is responsible for a syndromic developmental disorder associated with intellectual disability.
    Bogaert E; Garde A; Gautier T; Rooney K; Duffourd Y; LeBlanc P; van Reempts E; Tran Mau-Them F; Wentzensen IM; Au KS; Richardson K; Northrup H; Gatinois V; Geneviève D; Louie RJ; Lyons MJ; Laulund LW; Brasch-Andersen C; Maxel Juul T; El It F; Marle N; Callier P; Relator R; Haghshenas S; McConkey H; Kerkhof J; Cesario C; Novelli A; Brunetti-Pierri N; Pinelli M; Pennamen P; Naudion S; Legendre M; Courdier C; Trimouille A; Fenzy MD; Pais L; Yeung A; Nugent K; Roeder ER; Mitani T; Posey JE; Calame D; Yonath H; Rosenfeld JA; Musante L; Faletra F; Montanari F; Sartor G; Vancini A; Seri M; Besmond C; Poirier K; Hubert L; Hemelsoet D; Munnich A; Lupski JR; Philippe C; Thauvin-Robinet C; Faivre L; Sadikovic B; Govin J; Dermaut B; Vitobello A
    Am J Hum Genet; 2023 May; 110(5):790-808. PubMed ID: 37071997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delineation of a KDM2B-related neurodevelopmental disorder and its associated DNA methylation signature.
    van Jaarsveld RH; Reilly J; Cornips MC; Hadders MA; Agolini E; Ahimaz P; Anyane-Yeboa K; Bellanger SA; van Binsbergen E; van den Boogaard MJ; Brischoux-Boucher E; Caylor RC; Ciolfi A; van Essen TAJ; Fontana P; Hopman S; Iascone M; Javier MM; Kamsteeg EJ; Kerkhof J; Kido J; Kim HG; Kleefstra T; Lonardo F; Lai A; Lev D; Levy MA; Lewis MES; Lichty A; Mannens MMAM; Matsumoto N; Maya I; McConkey H; Megarbane A; Michaud V; Miele E; Niceta M; Novelli A; Onesimo R; Pfundt R; Popp B; Prijoles E; Relator R; Redon S; Rots D; Rouault K; Saida K; Schieving J; Tartaglia M; Tenconi R; Uguen K; Verbeek N; Walsh CA; Yosovich K; Yuskaitis CJ; Zampino G; Sadikovic B; Alders M; Oegema R
    Genet Med; 2023 Jan; 25(1):49-62. PubMed ID: 36322151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation episignature and comparative epigenomic profiling for Pitt-Hopkins syndrome caused by TCF4 variants.
    van der Laan L; Lauffer P; Rooney K; Silva A; Haghshenas S; Relator R; Levy MA; Trajkova S; Huisman SA; Bijlsma EK; Kleefstra T; van Bon BW; Baysal Ö; Zweier C; Palomares-Bralo M; Fischer J; Szakszon K; Faivre L; Piton A; Mesman S; Hochstenbach R; Elting MW; van Hagen JM; Plomp AS; Mannens MMAM; Alders M; van Haelst MM; Ferrero GB; Brusco A; Henneman P; Sweetser DA; Sadikovic B; Vitobello A; Menke LA
    HGG Adv; 2024 Jul; 5(3):100289. PubMed ID: 38571311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic regulation of
    Lewerissa EI; Nadif Kasri N; Linda K
    Autophagy; 2024 Jan; 20(1):15-28. PubMed ID: 37674294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation episignature, extension of the clinical features, and comparative epigenomic profiling of Hao-Fountain syndrome caused by variants in USP7.
    van der Laan L; Karimi K; Rooney K; Lauffer P; McConkey H; Caro P; Relator R; Levy MA; Bhai P; Mignot C; Keren B; Briuglia S; Sobering AK; Li D; Vissers LELM; Dingemans AJM; Valenzuela I; Verberne EA; Misra-Isrie M; Zwijnenburg PJG; Waisfisz Q; Alders M; Sailer S; Schaaf CP; Mannens MMAM; Sadikovic B; van Haelst MM; Henneman P
    Genet Med; 2024 Mar; 26(3):101050. PubMed ID: 38126281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of DNA methylation episignature for the intellectual developmental disorder, autosomal dominant 21 syndrome, caused by variants in the CTCF gene.
    Karimi K; Mol MO; Haghshenas S; Relator R; Levy MA; Kerkhof J; McConkey H; Brooks A; Zonneveld-Huijssoon E; Gerkes EH; Tedder ML; Vissers L; Salzano E; Piccione M; Asaftei SD; Carli D; Mussa A; Shukarova-Angelovska E; Trajkova S; Brusco A; Merla G; Alders MM; Bouman A; Sadikovic B
    Genet Med; 2024 Mar; 26(3):101041. PubMed ID: 38054406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Episignatures Stratifying Helsmoortel-Van Der Aa Syndrome Show Modest Correlation with Phenotype.
    Breen MS; Garg P; Tang L; Mendonca D; Levy T; Barbosa M; Arnett AB; Kurtz-Nelson E; Agolini E; Battaglia A; Chiocchetti AG; Freitag CM; Garcia-Alcon A; Grammatico P; Hertz-Picciotto I; Ludena-Rodriguez Y; Moreno C; Novelli A; Parellada M; Pascolini G; Tassone F; Grice DE; Di Marino D; Bernier RA; Kolevzon A; Sharp AJ; Buxbaum JD; Siper PM; De Rubeis S
    Am J Hum Genet; 2020 Sep; 107(3):555-563. PubMed ID: 32758449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation episignature in Gabriele-de Vries syndrome.
    Cherik F; Reilly J; Kerkhof J; Levy M; McConkey H; Barat-Houari M; Butler KM; Coubes C; Lee JA; Le Guyader G; Louie RJ; Patterson WG; Tedder ML; Bak M; Hammer TB; Craigen W; Démurger F; Dubourg C; Fradin M; Franciskovich R; Frengen E; Friedman J; Palares NR; Iascone M; Misceo D; Monin P; Odent S; Philippe C; Rouxel F; Saletti V; Strømme P; Thulin PC; Sadikovic B; Genevieve D
    Genet Med; 2022 Apr; 24(4):905-914. PubMed ID: 35027293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and genetic analysis of children with unexplained neurodevelopmental delay and neurodevelopmental comorbidities in a Chinese cohort using trio-based whole-exome sequencing.
    Wu R; Li X; Meng Z; Li P; He Z; Liang L
    Orphanet J Rare Dis; 2024 May; 19(1):205. PubMed ID: 38764027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense and truncating variants in CHD5 in a dominant neurodevelopmental disorder with intellectual disability, behavioral disturbances, and epilepsy.
    Parenti I; Lehalle D; Nava C; Torti E; Leitão E; Person R; Mizuguchi T; Matsumoto N; Kato M; Nakamura K; de Man SA; Cope H; Shashi V; ; Friedman J; Joset P; Steindl K; Rauch A; Muffels I; van Hasselt PM; Petit F; Smol T; Le Guyader G; Bilan F; Sorlin A; Vitobello A; Philippe C; van de Laar IMBH; van Slegtenhorst MA; Campeau PM; Au PYB; Nakashima M; Saitsu H; Yamamoto T; Nomura Y; Louie RJ; Lyons MJ; Dobson A; Plomp AS; Motazacker MM; Kaiser FJ; Timberlake AT; Fuchs SA; Depienne C; Mignot C
    Hum Genet; 2021 Jul; 140(7):1109-1120. PubMed ID: 33944996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deleterious Variation in BRSK2 Associates with a Neurodevelopmental Disorder.
    Hiatt SM; Thompson ML; Prokop JW; Lawlor JMJ; Gray DE; Bebin EM; Rinne T; Kempers M; Pfundt R; van Bon BW; Mignot C; Nava C; Depienne C; Kalsner L; Rauch A; Joset P; Bachmann-Gagescu R; Wentzensen IM; McWalter K; Cooper GM
    Am J Hum Genet; 2019 Apr; 104(4):701-708. PubMed ID: 30879638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.